Nanotechnology-based injection significantly improved knee pain and function with favorable safety and efficacy sustained over 6 months following ...

That does not mean physical therapy is appropriate for every condition, nor does it mean that MRIs, medications, injections, ...

Experts say the peptide craze is part of a broader phenomenon, as patients look beyond the regulated health system to address ...

The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a ...

Semaglutide and Asthma? The popular GLP-1 diabetes and weight-loss injection may be linked to fewer asthma attacks and COPD ...

Explore the preclinical research catching our eye in September 2026, from siRNA and in vivo CRISPR to targeted protein ...

Specialty medications have become routine care for people managing serious, long-term illnesses. These therapies often treat conditions that do not respond well to standard prescriptions. Many require ...

RXRG001 is a proprietary circular RNA therapy encoding human aquaporin-1 The US Food and Drug Administration (FDA) has ...

Research into alpha-2-macroglobulin is shedding light on its potential role as an anti-inflammatory orthobiologic for ...

Detailed Phase 3 CANOPY-HCH-3 data in children living with hypochondroplasia also featured in a late-breaking oral presentation at the European Society for Paediatric Endocrinology (ESPE) 2026 Annual ...

The United States has now named six Chinese AI firms accused of waging industrial-scale attacks distilling US frontier AI model capabilities and perhaps sparing billions in Chinese development costs.

On Wednesday, BioMarin unveiled detailed results from the phase 3 CANOPY-HCH-3 trial assessing Voxzogo in children with hypochondroplasia (HCH), a milder form of achondroplasia, where the company ...